Wolfdieter Springer, PhD, is a scientific leader in molecular pathogenesis of Parkinson’s disease and studies cell biology in aging and age-dependent disorders.
Dr. Springer is an Associate Professor in the Department of Neuroscience at the Mayo Clinic in Florida and head of the Parkinson’s Disease Cell Biology Laboratory. For more than 15 years, his work has revolved around the molecular and cellular mechanisms underlying the pathogenesis of Parkinson’s disease and related disorders. Dr. Springer has helped identify the PINK1/Parkin-directed mitochondrial quality control pathway that serves to selectively remove damaged organelles via the autophagy/lysosome system (mitophagy). He is part of a team of internationally recognized researchers and clinicians with specialty training in Parkinson’s disease and movement disorders supported by the American Parkinson Disease Association.
Dr. Springer received his Master of Science in biology from the University of Regensburg and earned his doctorate in biochemistry from the Ludwig-Maximilians-University, both of which are located in Germany.